Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | MicrobiomeTrials← Back to trialsNCT07702461
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-12Est. Completion: 2026-10
Enrollment target: 300 participants Locations- The Ohio State University, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026